MASIMO CORP 4
4 · MASIMO CORP · Filed Feb 23, 2017
Insider Transaction Report
Form 4
MASIMO CORPMASI
de Raad Mark
EVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-02-23$21.97/sh+6,000$131,820→ 8,660 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-02-22$20.19/sh−5,297$106,946→ 9,703 totalExercise: $20.19From: 2012-10-27Exp: 2021-10-27→ Common Stock (5,297 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-02-23$21.97/sh−6,000$131,820→ 24,000 totalExercise: $21.97From: 2014-05-28Exp: 2023-05-28→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2017-02-21$20.19/sh+15,000$302,850→ 17,660 total - Sale
Common Stock
2017-02-23$87.50/sh−9,703$849,013→ 2,660 total - Exercise/Conversion
Common Stock
2017-02-23$20.19/sh+9,703$195,904→ 12,363 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-02-21$20.19/sh−15,000$302,850→ 15,000 totalExercise: $20.19From: 2012-10-27Exp: 2021-10-27→ Common Stock (15,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-02-23$20.19/sh−9,703$195,904→ 0 totalExercise: $20.19From: 2012-10-27Exp: 2021-10-27→ Common Stock (9,703 underlying) - Exercise/Conversion
Common Stock
2017-02-22$20.19/sh+5,297$106,946→ 7,957 total - Sale
Common Stock
2017-02-22$87.50/sh−5,297$463,488→ 2,660 total - Sale
Common Stock
2017-02-21$85.00/sh−15,000$1,275,000→ 2,660 total
Footnotes (3)
- [F1]The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of December 16, 2016, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- [F2]This option was granted on October 27, 2011 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- [F3]This option was granted on May 28, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.